Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
56.10
+1.00 (1.81%)
At close: Aug 14, 2025
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.03 billion as of August 15, 2025. Its market cap has decreased by -42.22% in one year.
Market Cap
6.03B
Enterprise Value
10.76B
Revenue
8.47B
Ranking
n/a
PE Ratio
13.45
Stock Price
56.10
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.03B, an increase of 112.50%. That is a compound annual growth rate of 30.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 6.03B | 15.43% |
Dec 30, 2024 | 5.22B | -42.42% |
Dec 28, 2023 | 9.07B | 7.79% |
Dec 29, 2022 | 8.41B | 196.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grameenphone | 425.75B |
Square Pharmaceuticals PLC. | 199.72B |
British American Tobacco Bangladesh Company | 156.92B |
Robi Axiata PLC. | 140.38B |
BRAC Bank PLC. | 136.38B |
Walton Hi-Tech Industries | 135.14B |
Bangladesh Export Import Company | 103.85B |
Marico Bangladesh | 90.91B |